Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

Share Price is delayed by 15 minutes
Get Live Data
83.00    0.40 (0.48%)
Bid:
82.00
Ask:
84.00
Spread: 2.00 (2.439%)
Market Cap: £87.21m
SDI Live PriceLast checked at - London Stock Exchange

Intraday SDI Group Share Chart

Trading Update

6 May 2022 07:00

RNS Number : 5348K
SDI Group PLC
06 May 2022
 

SDI Group plc

("SDI", "SDI Group", the "Company", or the "Group")

Trading Update

 

SDI Group plc, the AIM quoted Group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, is pleased to provide an update on trading for the year ended 30 April 2022.

Financial results ahead of expectations

Subject to finalisation of the accounts and audit, we expect revenues and profits for the year to materially exceed current market expectations1. Sales are expected to be approximately £49m (FY2021: £35.1m). We expect organic sales growth2 for the year to be in excess of 20%, which further builds on last year's 19% organic growth. We are also pleased with the additional sales contributions from acquired businesses Monmouth Scientific (acquired December 2020), Uniform Engineering (February 2021), Scientific Vacuum Systems (January 2022) and Safelab Systems (March 2022). Adjusted Profit Before Tax3 is expected to be at least £10.5m (FY2021: £7.4m). We also expect to report very strong operational cashflows, significantly ahead of market expectations.

Strength of the business model and prospects for 2023

The past year has presented unprecedented operational challenges, with an intermittent COVID-19 recovery, the after-effects of Brexit and a war in Ukraine all creating uncertainty and generating significant supply chain difficulties and unwelcome inflationary cost pressure. The Group's federated structure and our diligent staff have allowed us to respond to the challenge with record output and improved profitability, providing customers with the products they need. Our Atik Camera business continues to see strong demand from PCR OEM manufacturers. We have no material direct exposure to Ukraine or Russia. Having continued to invest in our current businesses and in acquiring complementary businesses, we expect FY2023 to be the Group's best year yet, also ahead of current market expectations.

Ken Ford, Chairman of SDI, commented: "We have executed again on all facets of our buy and build strategy, delivering record performance in FY2022 and setting up what looks like another record year in FY2023."

 

1. Analysts from our Broker finnCap Limited and from Progressive Equity Research regularly provide research on the Company, accessible from our website, and the Group considers the average of their forecasts to represent market expectations (prior to this Trading Update) for FY2022 being Revenue of £46.65m and Adjusted Profit Before Tax of £9.65m.

2. Organic sales growth is the year-on-year change in sales for all of our businesses starting from their 13th month within the Group, expressed as a percentage of the Group's prior year sales.

3. Before reorganisation costs, acquisition costs, amortisation / impairment of acquired intangibles and share based payment costs.

 

Enquiries

SDI Group plc 01223 320480

Ken Ford, Chairman

Mike Creedon, CEO

Jon Abell, CFO

www.sdigroup.com

 

finnCap Ltd 020 7220 0500

Ed Frisby/Kate Bannatyne/Milesh Hindocha - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

 

About SDI Group plc:

SDI designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, manufacturing, precision optics and art conservation. SDI operates through its company divisions: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries, Chell Instruments, Monmouth Scientific, Uniform Engineering and Safelab Systems.

SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions.

www.sdigroup.com

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZGGKNKRGZZM
Date   Source Headline
10th Jun 20267:00 amRNSDirectorate change
21st May 20267:00 amRNSTrading Update
11th May 20261:00 pmRNSDirectorate change
10th Apr 20264:40 pmRNSHolding(s) in Company
9th Apr 20265:05 pmRNSHolding(s) in Company
20th Mar 202610:45 amRNSHolding(s) in Company
17th Mar 20267:00 amRNS-RNews from Portfolio Companies
17th Mar 20267:00 amRNS-RNews from Portfolio Companies
13th Mar 20261:41 pmRNSHolding(s) in Company
2nd Mar 20266:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20263:45 pmRNSHolding(s) in Company
13th Feb 20267:00 amRNSAcquisition of PRP Optoelectronics
3rd Dec 20257:00 amRNSInterim Results
17th Nov 20257:00 amRNSNotice of Results and Investor Presentation
7th Oct 20254:49 pmRNSAIM Rule 17 and Schedule 2(g) Update
6th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
25th Sep 20257:00 amRNSGrant of Share Option Awards
24th Sep 20252:30 pmRNSResult of AGM
24th Sep 20257:00 amRNSAGM Trading Update
19th Sep 20253:31 pmRNSHolding(s) in Company
21st Aug 20257:00 amRNSPosting of Annual Report and Notice of AGM
30th Jul 20257:00 amRNSFinal Results
21st Jul 20257:00 amRNSNotice of Results and Investor Presentation
26th Jun 20252:14 pmRNSAIM Rule 17 and Schedule 2(g) Update
6th Jun 20257:00 amRNSAcquisition of Severn Thermal Solutions
19th May 20257:00 amRNSTrading Update
6th May 20257:00 amRNS-RInspecVision awarded King's Award for Enterprise
11th Apr 20253:00 pmRNSHolding(s) in Company
4th Apr 20251:55 pmRNSDirector / PDMR Shareholding
4th Apr 20257:00 amRNSAcquisition of Collins Walker
20th Mar 20257:00 amRNS-RNews from Portfolio Companies
14th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Dec 20247:00 amRNSInterim Results
14th Nov 20247:00 amRNSNotice of Results and Investor Presentation
30th Oct 20247:00 amRNSAcquisition of InspecVision
14th Oct 202410:00 amRNSHoldings in Company
7th Oct 20245:00 pmRNSHolding(s) in Company
27th Sep 20247:00 amRNSShare Option Awards
26th Sep 20243:00 pmRNSDirector/PDMR Shareholding
26th Sep 20241:05 pmRNSResult of AGM
26th Sep 20247:00 amRNSAGM Trading Update
28th Aug 20247:00 amRNSPosting of Annual Report & Accounts & AGM Notice
30th Jul 20247:00 amRNSFinal Results
23rd Jul 20241:00 pmRNSNotice of Results and Investor Presentation
4th Jul 202411:45 amRNSHolding(s) in Company
3rd Jul 20244:25 pmRNSHolding(s) in Company
23rd May 202411:30 amRNSHolding(s) in Company
20th May 20247:00 amRNSTrading Update
3rd Apr 20242:15 pmRNSExercise of Share Options and Total Voting Rights
18th Mar 202412:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.